NDC 60687-534

Atovaquone

Atovaquone

Atovaquone is a Oral Suspension in the Human Prescription Drug category. It is labeled and distributed by American Health Packaging. The primary component is Atovaquone.

Product ID60687-534_ab0cb376-924d-5dde-e053-2a95a90aa655
NDC60687-534
Product TypeHuman Prescription Drug
Proprietary NameAtovaquone
Generic NameAtovaquone
Dosage FormSuspension
Route of AdministrationORAL
Marketing Start Date2020-09-01
Marketing CategoryANDA / ANDA
Application NumberANDA210692
Labeler NameAmerican Health Packaging
Substance NameATOVAQUONE
Active Ingredient Strength750 mg/5mL
Pharm ClassesAntimalarial [EPC],Antiprotozoal [EPC]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 60687-534-78

7 TRAY in 1 CASE (60687-534-78) > 6 CUP, UNIT-DOSE in 1 TRAY (60687-534-52) > 5 mL in 1 CUP, UNIT-DOSE (60687-534-40)
Marketing Start Date2020-09-01
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Atovaquone" or generic name "Atovaquone"

NDCBrand NameGeneric Name
0121-0888AtovaquoneAtovaquone
0121-0898AtovaquoneAtovaquone
0121-1796AtovaquoneAtovaquone
0904-7064AtovaquoneAtovaquone
16714-900atovaquoneatovaquone
31722-629AtovaquoneAtovaquone
50268-086AtovaquoneAtovaquone
51407-642AtovaquoneAtovaquone
60687-534AtovaquoneAtovaquone
65162-693ATOVAQUONEATOVAQUONE
66689-062AtovaquoneAtovaquone
66993-062Atovaquoneatovaquone
68180-282AtovaquoneAtovaquone
68462-421atovaquoneatovaquone
70166-488AtovaquoneAtovaquone
10702-223Atovaquone Oral SuspensionAtovaquone
0173-0547MEPRONatovaquone
0173-0665MEPRONatovaquone

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.